430 related articles for article (PubMed ID: 19571620)
1. [Analysis of clinical characteristics and S gene mutation of hepatitis B virus (HBV) in patients with hepatitis B surface antigen RIA negative and HBV DNA positive].
Sohn YH; Oh HB; Ko SY; Lim YS; Kwon OJ
Korean J Lab Med; 2009 Jun; 29(3):224-30. PubMed ID: 19571620
[TBL] [Abstract][Full Text] [Related]
2. De novo activation of HBV with escape mutations from hepatitis B surface antibody after living donor liver transplantation.
Ueda Y; Marusawa H; Egawa H; Okamoto S; Ogura Y; Oike F; Nishijima N; Takada Y; Uemoto S; Chiba T
Antivir Ther; 2011; 16(4):479-87. PubMed ID: 21685535
[TBL] [Abstract][Full Text] [Related]
3. Escape hepatitis B virus mutations in recipients of antibody to hepatitis B core antigen-positive liver grafts receiving hepatitis B immunoglobulins.
Roche B; Roque-Afonso AM; Sebagh M; Delvart V; Duclos-Vallee JC; Castaing D; Samuel D
Liver Transpl; 2010 Jul; 16(7):885-94. PubMed ID: 20583085
[TBL] [Abstract][Full Text] [Related]
4. Novel immunoassay for the detection of hepatitis B surface 'escape' mutants and its application in liver transplant recipients.
Ijaz S; Torre F; Tedder RS; Williams R; Naoumov NV
J Med Virol; 2001 Mar; 63(3):210-6. PubMed ID: 11170059
[TBL] [Abstract][Full Text] [Related]
5. Substantial variation in the hepatitis B surface antigen (HBsAg) in hepatitis B virus (HBV)-positive patients from South Africa: Reliable detection of HBV by the Elecsys HBsAg II assay.
Gencay M; Vermeulen M; Neofytos D; Westergaard G; Pabinger S; Kriegner A; Seffner A; Gohl P; Huebner K; Nauck M; Kaminski WE
J Clin Virol; 2018 Apr; 101():38-43. PubMed ID: 29414186
[TBL] [Abstract][Full Text] [Related]
6. An improved Abbott ARCHITECT assay for the detection of hepatitis B virus surface antigen (HBsAg).
Lou SC; Pearce SK; Lukaszewska TX; Taylor RE; Williams GT; Leary TP
J Clin Virol; 2011 May; 51(1):59-63. PubMed ID: 21367654
[TBL] [Abstract][Full Text] [Related]
7. Genotype, phylogenetic analysis, and transmission pattern of occult hepatitis B virus (HBV) infection in families of asymptomatic HBsAg carriers.
Datta S; Banerjee A; Chandra PK; Chowdhury A; Chakravarty R
J Med Virol; 2006 Jan; 78(1):53-9. PubMed ID: 16299727
[TBL] [Abstract][Full Text] [Related]
8. An efficacy and cost-effectiveness analysis of combination hepatitis B immune globulin and lamivudine to prevent recurrent hepatitis B after orthotopic liver transplantation compared with hepatitis B immune globulin monotherapy.
Han SH; Ofman J; Holt C; King K; Kunder G; Chen P; Dawson S; Goldstein L; Yersiz H; Farmer DG; Ghobrial RM; Busuttil RW; Martin P
Liver Transpl; 2000 Nov; 6(6):741-8. PubMed ID: 11084061
[TBL] [Abstract][Full Text] [Related]
9. [A study on mutations of the overlapping hepatitis B virus surface and polymerase gene in patients with HBV reinfection after liver transplantations].
Song HL; Shen ZY; Wang J; Zheng WP; Wang ZL
Zhonghua Gan Zang Bing Za Zhi; 2008 Apr; 16(4):265-9. PubMed ID: 18423147
[TBL] [Abstract][Full Text] [Related]
10. Correlation of HBV DNA and monoclonal reactivity to HBsAg in serum of patients with HBV infection.
Zeldis JB; Ben-Porath E; Enat R; Kirsch K; Wands J
J Virol Methods; 1986 Sep; 14(2):153-66. PubMed ID: 3771732
[TBL] [Abstract][Full Text] [Related]
11. Occult hepatitis B virus infection with positive hepatitis B e antigen.
Han Z; Liu Y; Pan J; Bi Y; Liu J; Zhou YH
Clin Chim Acta; 2015 Jan; 438():266-8. PubMed ID: 25218700
[TBL] [Abstract][Full Text] [Related]
12. An ultra-sensitive Abbott ARCHITECT
Lou S; Taylor R; Pearce S; Kuhns M; Leary T
J Clin Virol; 2018 Aug; 105():18-25. PubMed ID: 29843004
[TBL] [Abstract][Full Text] [Related]
13. Molecular and serological characterization of hepatitis B vaccine breakthrough infections in serial samples from two plasma donors.
Kuhns MC; McNamara AL; Holzmayer V; Cloherty GA
Virol J; 2019 Apr; 16(1):43. PubMed ID: 30943997
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation.
Faria LC; Gigou M; Roque-Afonso AM; Sebagh M; Roche B; Fallot G; Ferrari TC; Guettier C; Dussaix E; Castaing D; Brechot C; Samuel D
Gastroenterology; 2008 Jun; 134(7):1890-9; quiz 2155. PubMed ID: 18424269
[TBL] [Abstract][Full Text] [Related]
15. New hepatitis B virus mutant form in a blood donor that is undetectable in several hepatitis B surface antigen screening assays.
Jongerius JM; Wester M; Cuypers HT; van Oostendorp WR; Lelie PN; van der Poel CL; van Leeuwen EF
Transfusion; 1998 Jan; 38(1):56-9. PubMed ID: 9482395
[TBL] [Abstract][Full Text] [Related]
16. Long-term lamivudine monotherapy prevents development of hepatitis B virus infection in hepatitis B surface-antigen negative liver transplant recipients from hepatitis B core-antibody-positive donors.
Prakoso E; Strasser SI; Koorey DJ; Verran D; McCaughan GW
Clin Transplant; 2006; 20(3):369-73. PubMed ID: 16824156
[TBL] [Abstract][Full Text] [Related]
17. Immunocompromised patients with HBsAg a determinant mutants: comparison of HBsAg diagnostic assays.
Veropalumbo E; Marrone A; Vallefuoco L; Perruolo G; Orlando R; Scordino F; Tosone G; Zampino R; Trani B; Genovese A; Spadaro G; D'Orio C; Portella G
Intervirology; 2010; 53(3):183-7. PubMed ID: 20197685
[TBL] [Abstract][Full Text] [Related]
18. Infections by hepatitis B surface antigen gene mutants in Europe and North America.
Tabor E
J Med Virol; 2006; 78 Suppl 1():S43-7. PubMed ID: 16622882
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus genotypes and hepatitis B surface antigen mutations in family contacts of hepatitis B virus infected patients with occult hepatitis B virus infection.
Kumar GT; Kazim SN; Kumar M; Hissar S; Chauhan R; Basir SF; Sarin SK
J Gastroenterol Hepatol; 2009 Apr; 24(4):588-98. PubMed ID: 19207682
[TBL] [Abstract][Full Text] [Related]
20. The analytic sensitivity and mutant detection capability of six hepatitis B surface antigen assays.
La'ulu SL; Roberts WL
Am J Clin Pathol; 2006 May; 125(5):748-51. PubMed ID: 16707377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
